Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer
Publication date
2020-11-16
Authors
Lokuhetty, Menaka Dilani S.
Wijesinghe, Harshima D.
Damen, Johanna Aag
Lee, Teresa
White, Valerie A.
Cree, Ian A.
Indave, Blanca Iciar
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. Primary objectives The primary objective is to summarise available evidence on the overall prognostic value of androgen receptor (AR) expression, in addition to hormone receptors and HER2 status, for predicting survival in women with early breast cancer. Secondary objectives The secondary objectives are to evaluate disease-free survival, breast cancer-specific survival, and metastasis-free survival as prognostic outcomes.
Keywords
Taverne, Pharmacology (medical)
Citation
Lokuhetty, M D S, Wijesinghe, H D, Damen, J A A G, Lee, T, White, V A, Cree, I A & Indave, B I 2020, 'Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer', Cochrane Database of Systematic Reviews, vol. 2020, no. 11, CD013784. https://doi.org/10.1002/14651858.CD013784